Asthma and Demyelination

Summary:

Demyelination is found among people with Asthma, especially for people who are female, 60+ old.

The study analyzes which people have Demyelination with Asthma. It is created by eHealthMe based on reports of 32 people who have Asthma from the Food and Drug Administration (FDA), and is updated regularly. You can use the study as a second opinion to make health care decisions.

What is Asthma?

Asthma is found to be associated with 2,088 drugs and 2,606 conditions by eHealthMe. Check the latest studies of Asthma.

What is Demyelination?

Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function) is found to be associated with 464 drugs and 669 conditions by eHealthMe. Check the latest studies of Demyelination.



On Jul, 14, 2026

32 people who have Asthma and Demyelination are studied.

Would you have Demyelination when you have Asthma?

Gender of people who have Asthma and experienced Demyelination *:

  • female: 55.56 %
  • male: 44.44 %

Age of people who have Asthma and experienced Demyelination *:

  • 0-1: 0.0 %
  • 2-9: 0.0 %
  • 10-19: 4.55 %
  • 20-29: 0.0 %
  • 30-39: 9.09 %
  • 40-49: 27.27 %
  • 50-59: 22.73 %
  • 60+: 36.36 %

Common co-existing conditions for these people *:

  1. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 5 people, 15.62%
  2. Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 5 people, 15.62%
  3. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 4 people, 12.50%
  4. Neuralgia (pain in one or more nerves): 4 people, 12.50%
  5. Constipation: 4 people, 12.50%
  6. Lumbar Spinal Stenosis (a medical condition in which the spinal canal narrows and compresses the spinal cord and nerves at the level of the lumbar bone): 4 people, 12.50%
  7. Gastric Ulcer (stomach ulcer): 4 people, 12.50%
  8. Nasal Polyps (masses that develop in the lining of the nose): 3 people, 9.38%
  9. Crohn's Disease (a condition that causes inflammation of the gastrointestinal tract): 3 people, 9.38%
  10. Muscle Spasticity (tight or stiff muscles and an inability to control those muscles): 3 people, 9.38%

Common drugs taken by these people *:

  1. Singulair: 8 people, 25.00%
  2. Xolair: 6 people, 18.75%
  3. Lyrica: 6 people, 18.75%
  4. Nexium: 6 people, 18.75%
  5. Symbicort: 5 people, 15.62%
  6. Albuterol: 5 people, 15.62%
  7. Neurontin: 4 people, 12.50%
  8. Orencia: 4 people, 12.50%
  9. Advair Diskus 100/50: 3 people, 9.38%
  10. Xopenex: 3 people, 9.38%

Common symptoms for these people *:

  1. Hypoaesthesia (reduced sense of touch or sensation): 6 people, 18.75%
  2. Fall: 5 people, 15.62%
  3. Gait Disturbance: 5 people, 15.62%
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 4 people, 12.50%
  5. Weakness: 4 people, 12.50%
  6. Allergic Granulomatous Angiitis (allergic inflammation of a blood vessel or lymph duct): 4 people, 12.50%
  7. Vasculitis (inflammation of a blood vessel or blood vessels): 4 people, 12.50%
  8. Mononeuritis Multiplex (a form of damage to one or more peripheral nerves): 3 people, 9.38%
  9. Hypogammaglobulinaemia (an abnormally low concentration of gamma globulin in the blood and increased risk of infection): 3 people, 9.38%
  10. Common Peroneal Nerve Dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes): 3 people, 9.38%

* Approximation only. Some reports may have incomplete information.

Do you take medications and have Demyelination?

- Check whether Demyelination is associated with a drug or a condition


Related studies:

Treatments, associated drugs and conditions:

All the drugs that are associated with Demyelination:

All the conditions that are associated with Demyelination:


How the study uses the data?

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

The study is based on Demyelination and Asthma, and their synonyms.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: